top of page

Selegiline oral (ELDEPRYL)    

Visualize Pharmacology

Selegiline Eldepryl mnemonic mascot Elderly Seals gills

Oral selegiline (Eldepryl) is a monoamine oxidase inhibitor used for Parkinson’s disease. At lower oral exposure it preferentially inhibits MAO-B, reducing dopamine breakdown. This selectivity diminishes as exposure increases.

Open selegiline in Ballicules.com console

Go to selegiline on ballicules.com

Selegiline ballicule depicting monoamine oxidase inhibition
Selegiline CYP2B6 substrate interaction avatar

Mechanism and mnemonic

“Elderly Seal’s gills” connects Eldepryl with selegiline. The Mao Zedong cue recalls MAO inhibition. The pegged decagon ballicule maps its pharmacology.

The interaction avatar illustrates CYP2B6 substrate metabolism. Amphetamine-related metabolites can contribute to insomnia.

Selegiline molecular structure skeletal formula

Formulation and interaction cautions

Higher exposure reduces MAO-B selectivity and increases tyramine-related risk. Serotonergic combinations can cause serotonin toxicity. Medication changes require attention to drug-specific washout intervals.

Go to selegiline transdermal on ballicules.com for the patch formulation used for depression.

bottom of page